SAFETY AND EFFICACY OF RECOMBINANT FACTOR IX FUSION PROTEIN IN PEDIATRIC PATIENTS WITH HEMOPHILIA B

被引：0
|
作者：
Chambost, Herve [1 ]
Drelich, Douglass [1 ]
Seifert, Wilfried [1 ]
Castaman, Giancarlo [1 ]
机构：
[1] CSL Behring, King Of Prussia, PA USA
来源：
PEDIATRIC BLOOD & CANCER | 2023年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
402
引用
收藏
页码：S175 / S175
页数：1
相关论文
共 50 条
  • [1] SAFETY AND EFFICACY OF RECOMBINANT FACTOR IX FUSION PROTEIN (RIX-FP) IN PUPS WITH HEMOPHILIA B
    Lemons, Richard
    Wang, Michael
    Curtin, Julie
    Lepatan, Lynda Mae
    Male, Christoph
    Peyvandi, Flora
    Von Depka, Mario
    [J]. PEDIATRIC BLOOD & CANCER, 2023, 70 : S174 - S175
  • [2] Post hoc longitudinal assessment of the efficacy and safety of recombinant factor IX Fc fusion protein in hemophilia B
    Shapiro, Amy D.
    Kulkarni, Roshni
    Ragni, Margaret V.
    Chambost, Herve
    Mahlangu, Johnny
    Oldenburg, Johannes
    Nolan, Beatrice
    Ozelo, Margareth C.
    Foster, Meredith C.
    Willemze, Annemieke
    Barnowski, Christopher
    Jain, Nisha
    Winding, Bent
    Dumont, Jennifer
    Lethagen, Stefan
    Barnes, Chris
    Pasi, K. John
    [J]. BLOOD ADVANCES, 2023, 7 (13) : 3049 - 3057
  • [3] SAFETY, EFFICACY AND PHARMACOKINETICS OF A RECOMBINANT FACTOR IX (BAX326) IN PREVIOUSLY-TREATED PEDIATRIC PATIENTS WITH HEMOPHILIA B
    Urasinski, Tomasz
    Stasyshyn, Oleksandra
    Andreeva, Tatiana
    Rusen, Luminita
    Perina, Farida G.
    Oh, MyungShin
    Chapman, Miranda
    Pavlova, Borislava G.
    Wong, Wing-Yen
    Abbuehl, Brigitt E.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (06) : E30 - E30
  • [4] Efficacy and safety of long-acting recombinant fusion protein linking factor IX with albumin (rIX-FP) in hemophilia B patients undergoing surgery
    Karim, Faraizah Abdul
    Lepatan, Lynda Mae
    Lienhart, Anne-Marie
    Lopez Fernandez, Maria Fernanda
    Mahlangu, Johnny
    Pabinger, Ingrid
    Li, Yanyan
    Wolko, Denise
    Voigt, Christine
    Jacobs, Iris
    [J]. HAEMOPHILIA, 2016, 22 : 44 - 44
  • [5] Phase 3 Study of Recombinant Factor IX Fc Fusion Protein in Hemophilia B
    Powell, Jerry S.
    Pasi, K. John
    Ragni, Margaret V.
    Ozelo, Margareth C.
    Valentino, Leonard A.
    Mahlangu, Johnny N.
    Josephson, Neil C.
    Perry, David
    Manco-Johnson, Marilyn J.
    Apte, Shashikant
    Baker, Ross I.
    Chan, Godfrey C.
    Novitzky, Nicolas
    Wong, Raymond S.
    Krassova, Snejana
    Allen, Geoffrey
    Jiang, Haiyan
    Innes, Alison
    Li, Shuanglian
    Cristiano, Lynda M.
    Goyal, Jaya
    Sommer, Jurg M.
    Dumont, Jennifer A.
    Nugent, Karen
    Vigliani, Gloria
    Brennan, Aoife
    Luk, Alvin
    Pierce, Glenn F.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (24): : 2313 - 2323
  • [6] Biodistribution of recombinant factor IX, extended half-life recombinant factor IX Fc fusion protein, and glycoPEGylated recombinant factor IX in hemophilia B mice
    van der Flier, Arjan
    Hong, Vu
    Liu, Zhan
    Piepenhagen, Peter
    Ulinski, Gregory
    Dumont, Jennifer A.
    Orcutt, Kelly D.
    Goel, Apollina
    Peters, Robert
    Salas, Joe
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2023, 34 (06) : 353 - 363
  • [7] Efficacy of a recombinant factor IX in mouse models of hemophilia B
    Hoellriegl, W.
    Schiviz, A.
    Eder, B.
    Leidenmuehler, P.
    Ehrlich, H.
    Scheiflinger, F.
    Schwarz, H.
    Muchitsch, E.
    [J]. HAEMOPHILIA, 2012, 18 : 36 - 36
  • [8] Safety and pharmacokinetics of a novel recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in hemophilia B patients
    Santagostino, Elena
    Negrier, Claude
    Klamroth, Robert
    Tiede, Andreas
    Pabinger-Fasching, Ingrid
    Voigt, Christine
    Jacobs, Iris
    Morfini, Massimo
    [J]. BLOOD, 2012, 120 (12) : 2405 - 2411
  • [9] Human recombinant factor IX: safety and efficacy studies in hemophilia B patients previously treated with plasma-derived factor IX concentrates
    Haase, M
    [J]. BLOOD, 2002, 100 (12) : 4242 - 4242
  • [10] Human recombinant factor IX: safety and efficacy studies in hemophilia B patients previously treated with plasma-derived factor IX concentrates
    Roth, DA
    Kessler, CM
    Pasi, KJ
    Rup, B
    Courter, SG
    Tubridy, KL
    [J]. BLOOD, 2001, 98 (13) : 3600 - 3606
12345